BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18786477)

  • 41. Obesity is associated with increased morbidity after coronary artery bypass graft surgery in patients with renal insufficiency.
    Tolpin DA; Collard CD; Lee VV; Elayda MA; Pan W
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):873-9. PubMed ID: 19660351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of body mass index on outcomes of enhanced external counterpulsation therapy.
    McCullough PA; Silver MA; Kennard ED; Kelsey SF; Michaels AD;
    Am Heart J; 2006 Jan; 151(1):139. PubMed ID: 16368306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice.
    Wang TY; Ou FS; Roe MT; Harrington RA; Ohman EM; Gibler WB; Peterson ED
    Circulation; 2009 May; 119(18):2454-62. PubMed ID: 19398666
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low admission LDL-cholesterol is associated with increased 3-year all-cause mortality in patients with non ST segment elevation myocardial infarction.
    Al-Mallah MH; Hatahet H; Cavalcante JL; Khanal S
    Cardiol J; 2009; 16(3):227-33. PubMed ID: 19437396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The clinical importance of laboratory-defined aspirin resistance in patients presenting with non-ST elevation acute coronary syndromes.
    Acikel S; Yildirir A; Aydinalp A; Bal U; Kaynar G; Ozin B; Muderrisoglu H
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):427-32. PubMed ID: 19542882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of body mass index on early outcome of coronary artery bypass surgery.
    Shirzad M; Karimi A; Armadi SH; Marzban M; Abbasi K; Alinejad B; Moshtaghi N
    Minerva Chir; 2009 Feb; 64(1):17-23. PubMed ID: 19202532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nationwide trends in the age adjusted prevalence of non-ST elevation myocardial infarction (NSTEMI) across various races and gender in the USA.
    Movahed MR; Ramaraj R; Hashemzadeh M; Hashemzadeh M
    Acute Card Care; 2010 Jun; 12(2):58-62. PubMed ID: 20482327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department: a scientific statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain Centers.
    Gibler WB; Cannon CP; Blomkalns AL; Char DM; Drew BJ; Hollander JE; Jaffe AS; Jesse RL; Newby LK; Ohman EM; Peterson ED; Pollack CV; ; ;
    Circulation; 2005 May; 111(20):2699-710. PubMed ID: 15911720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of risk factors of ST segment elevation myocardial infarction in Turkish patients living in Central Anatolia.
    Aygül N; Ozdemir K; Abaci A; Aygül MU; Düzenli MA; Vatankulu MA; Yazici HU; Ozdoğru I; Karakaya E
    Anadolu Kardiyol Derg; 2009 Feb; 9(1):3-8. PubMed ID: 19196566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
    Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A;
    Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Initial risk stratification and presenting characteristics of patients with evolving myocardial infarctions.
    Miller CD; Fermann GJ; Lindsell CJ; Mahaffey KW; Peacock WF; Pollack CV; Hollander JE; Diercks DB; Gibler WB; Hoekstra JW;
    Emerg Med J; 2008 Aug; 25(8):492-7. PubMed ID: 18660397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary percutaneous coronary intervention in comatose survivors of cardiac arrest with ST-elevation acute myocardial infarction: a single-center experience in Florence.
    Valente S; Lazzeri C; Saletti E; Chiostri M; Gensini GF
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1083-7. PubMed ID: 18852577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.
    De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F;
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
    Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
    Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
    Jansson AM; Aukrust P; Ueland T; Smith C; Omland T; Hartford M; Caidahl K
    Circulation; 2009 Jun; 119(25):3181-8. PubMed ID: 19528340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention.
    Seyfarth M; Kastrati A; Mann JF; Ndrepepa G; Byrne RA; Schulz S; Mehilli J; Schömig A
    Am J Kidney Dis; 2009 Nov; 54(5):830-9. PubMed ID: 19592145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.
    Scirica BM; Morrow DA; Budaj A; Dalby AJ; Mohanavelu S; Qin J; Aroesty J; Hedgepeth CM; Stone PH; Braunwald E
    J Am Coll Cardiol; 2009 Apr; 53(16):1411-21. PubMed ID: 19371824
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.
    Munkhaugen J; Lydersen S; Widerøe TE; Hallan S
    Am J Kidney Dis; 2009 Oct; 54(4):638-46. PubMed ID: 19515474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of overall obesity and body fat distribution in predicting risk of mortality.
    Reis JP; Macera CA; Araneta MR; Lindsay SP; Marshall SJ; Wingard DL
    Obesity (Silver Spring); 2009 Jun; 17(6):1232-9. PubMed ID: 19197258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.